141 related articles for article (PubMed ID: 25617735)
1. Inhibition of STAT3/cyclinD1 pathway promotes chemotherapeutic sensitivity of colorectal caner.
Qin A; Yu Q; Gao Y; Tan J; Huang H; Qiao Z; Qian W
Biochem Biophys Res Commun; 2015 Feb; 457(4):681-7. PubMed ID: 25617735
[TBL] [Abstract][Full Text] [Related]
2. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
4. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
[TBL] [Abstract][Full Text] [Related]
5. STAT5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells.
Hong X; Chen G; Wang M; Lou C; Mao Y; Li Z; Zhang Y
Mol Med Rep; 2012 May; 5(5):1215-9. PubMed ID: 22367509
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
Wang Y; Liu X; Liu J; Zhang T
Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
[No Abstract] [Full Text] [Related]
9. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
[TBL] [Abstract][Full Text] [Related]
10. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between Stat3 signal transduction pathway and expression of cyclooxygenase-2 in colorectal cancer cells].
Zhang H; Wang S; Zhang YC; Ye YJ; Cui ZR; Fang WG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2899-904. PubMed ID: 16324362
[TBL] [Abstract][Full Text] [Related]
12. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
[TBL] [Abstract][Full Text] [Related]
13. Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells.
Zhang Q; Liu RX; Chan KW; Hu J; Zhang J; Wei L; Tan H; Yang X; Liu H
J Exp Clin Cancer Res; 2019 Jul; 38(1):320. PubMed ID: 31324203
[TBL] [Abstract][Full Text] [Related]
14. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
15. Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A.
Yan CM; Zhao YL; Cai HY; Miao GY; Ma W
Oncol Rep; 2015 Apr; 33(4):1737-44. PubMed ID: 25634668
[TBL] [Abstract][Full Text] [Related]
16. MiR-519d reduces the 5-fluorouracil resistance in colorectal cancer cells by down-regulating the expression of CCND1.
Huang R; Lin JY; Chi YJ
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2869-2875. PubMed ID: 29771440
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
19. Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells.
Moon SU; Kang MH; Sung JH; Kim JW; Lee JO; Kim YJ; Lee KW; Bang SM; Lee JS; Kim JH
Oncol Rep; 2015 Jan; 33(1):185-92. PubMed ID: 25370208
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 22 protects colorectal cancer cells from chemotherapy by activating the STAT3 pathway and inducing autocrine expression of interleukin 8.
Wu T; Wang Z; Liu Y; Mei Z; Wang G; Liang Z; Cui A; Hu X; Cui L; Yang Y; Liu CY
Clin Immunol; 2014 Oct; 154(2):116-26. PubMed ID: 25063444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
